- Technology R&D /
- Manufacturing Base /
- Patents /
- Quality Assurance
The company has strong technical strength. All products are independently developed. The R&D team now has 100 R&D engineers. With avant-garde and bold design concept, relying on basic theory and electronic, structure and material innovation, material application technology, electronic control technology and atomization innovation technology, the company provides customers with complete product solutions.
Atomization technology research institute
Joint Research Lab with Top Universities
Basic science research center
Institute of Materials Science
Institute of Electronic Science
The company has medical grade purification factories, (2 in normal operation, 1 under construction), with 158 planned assembly lines and a monthly capacity of 20 million disposable small cigarettes.
Phase 1 plant officially started operation in October 2020, covering an area of 6,838 square meters, with a construction area of 8,126 square meters and a design staff size of 1,300;
Phase 2 plant officially started operation in May 2022, covering an area of 17,965 square meters, with a building area of 7,128 square meters and a design staff size of 2,000;
Phase 3 plant will start trial operation in August 2022, covering an area of 8,300 square meters, with a construction area of 11,284 square meters and a design staff size of 1,800 people.
The company integrates high-quality R&D technical resources inside and outside the industry, always adheres to the avant-garde and bold design concept, the all-round layout of patent track, adheres to continuous development and innovation, and there is no upper limit on R&D investment. It is committed to realizing the diversification of product categories.
The company has a systematic and standardized preventive quality control system and a scientific and rigorous traceability system.